Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2773-2782
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2773
Table 5 Adverse events and satisfaction after intranasal dexmedetomidine and sufentanil
SUF dose, μg/kg
P value

0.2 (n = 9)
0.3 (n = 21)
Hypotension, n01
Nausea and vomiting, n12
Local mucosal irritation, n11
Endoscopist’s satisfaction, mean (SD)8.7 (0.9)8.5 (1.3)0.654
Patients’ satisfactions, mean (SD)9.0 (1.1)8.1 (1.0)0.052